Morgan Stanley’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.11M | Buy |
|
|||||
|
2025
Q1 | $1.6M | Sell |
|
|||||
|
2024
Q4 | $2.49M | Sell |
|
|||||
|
2024
Q3 | $3.46M | Buy |
|
|||||
|
2024
Q2 | $1.6M | Buy |
|
|||||
|
2024
Q1 | $1.11M | Sell |
|
|||||
|
2023
Q4 | $2.2M | Buy |
|
|||||
|
2023
Q3 | $464K | Buy |
|
|||||
|
2023
Q2 | $680K | Buy |
|
|||||
|
2023
Q1 | $381K | Buy |
|
|||||
|
2022
Q4 | $232K | Sell |
|
|||||
|
2022
Q3 | $140K | Sell |
|
|||||
|
2022
Q2 | $112K | Sell |
|
|||||
|
2022
Q1 | $191K | Sell |
|
|||||
|
2021
Q4 | $744K | Buy |
|
|||||
|
2021
Q3 | $1.19M | Sell |
|
|||||
|
2021
Q2 | $3.39M | Buy |
|
|||||
|
2021
Q1 | $2.72M | Buy |
|
|||||
|
2020
Q4 | $181K | Buy |
|
|||||
|
2020
Q3 | $19K | Sell |
|
|||||
|
2020
Q2 | $136K | Sell |
|
|||||
|
2020
Q1 | $2.31M | Buy |
|